artemisinin has been researched along with Diabetic Glomerulosclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Feng, H; Li, H; Liu, T; Ma, X; Wu, T; Yue, R; Zhou, Q | 1 |
Ling, C; Qi, S; Song, Y; Zhang, H | 1 |
Chen, Z; He, L; Lu, J; Xiang, M; Xiong, G | 1 |
1 review(s) available for artemisinin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Protective Effect and Possible Mechanisms of Artemisinin and Its Derivatives for Diabetic Nephropathy: A Systematic Review and Meta-Analysis in Animal Models.
Topics: Animals; Artemisinins; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Male; Models, Animal; Proteinuria | 2022 |
2 other study(ies) available for artemisinin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Artemisinin attenuates early renal damage on diabetic nephropathy rats through suppressing TGF-β1 regulator and activating the Nrf2 signaling pathway.
Topics: Animals; Artemisinins; Blood Glucose; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetic Nephropathies; Heme Oxygenase-1; Kidney; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta1 | 2020 |
Transcription profiling of artemisinin-treated diabetic nephropathy rats using high-throughput sequencing.
Topics: Animals; Artemisinins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Hypoglycemic Agents; Kidney; Male; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Sequence Analysis, RNA | 2019 |